<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26378" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Histology, Osteoblasts</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Henry</surname>
            <given-names>James P.</given-names>
          </name>
          <aff>LECOM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bordoni</surname>
            <given-names>Bruno</given-names>
          </name>
          <aff>Foundation Don Carlo Gnocchi IRCCS</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>James Henry declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bruno Bordoni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26378.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Osteoblasts are colloquially&#x000a0;referred to as cells that "build" bone.&#x000a0;These cells are directly responsible for osteogenesis (or ossification). Osteoblasts synthesize and&#x000a0;deposit organic bone matrix (osteoid) proteins that will&#x000a0;mineralize in both developing skeletons and during the process of&#x000a0;bone remodeling that occurs continuously throughout an individual's life.<xref ref-type="bibr" rid="article-26378.r1">[1]</xref>&#x000a0;</p>
        <p>Bone is approximately&#x000a0;10% water, 30% organic, and 60% inorganic. The organic component is approximately 85 to 90%&#x000a0;collagen (primarily type 1 -resisting tensile forces), proteoglycans (resisting compressive forces), non-collagenous proteins (osteocalcin and osteonectin) and glycoproteins (osteopontin).&#x000a0;The inorganic component, or mineralized matrix, is composed of hydroxyapatite crystals [Ca10(PO4)6(OH)2] that provides protection and support while serving as the body's repository for calcium and phosphate.<xref ref-type="bibr" rid="article-26378.r2">[2]</xref><xref ref-type="bibr" rid="article-26378.r3">[3]</xref><xref ref-type="bibr" rid="article-26378.r4">[4]</xref><xref ref-type="bibr" rid="article-26378.r5">[5]</xref>&#x000a0;Osteoblasts also indirectly regulate osteoclast formation and bone remodeling by cell-cell contact, paracrine signaling, and cell-bone matrix interaction.<xref ref-type="bibr" rid="article-26378.r6">[6]</xref><xref ref-type="bibr" rid="article-26378.r7">[7]</xref></p>
        <p>Osteoblasts&#x000a0;derive from two embryonic populations of mesenchymal stromal&#x000a0;cells (or mesenchymal stem cells, MSCs).&#x000a0;MSCs&#x000a0;originating from the neural ectoderm can directly differentiate into osteoprogenitor cells&#x000a0;that will become osteoblasts and form bone through intramembranous ossification (i.e., squamous bones of the calvaria and clavicle). MSCs originating from the paraxial mesoderm differentiate into axial skeleton osteoblasts, while the MSCs of the lateral plate mesoderm form osteoblasts of the appendicular skeleton. The axial and appendicular skeleton develop by endochondral ossification, with these osteoblasts deriving&#x000a0;from intermediate perichondral cells or hypertrophic chondrocytes.&#x000a0;Both the indirect and direct&#x000a0;processes converge at osteoprogenitor cells (or preosteoblasts).<xref ref-type="bibr" rid="article-26378.r8">[8]</xref>&#x000a0;Osteoblasts are induced from the osteoprogenitor cells by numerous&#x000a0;signals. Understanding of the osteogenic lineage remains incomplete.<xref ref-type="bibr" rid="article-26378.r9">[9]</xref></p>
      </sec>
      <sec id="article-26378.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Bone is a specialized connective tissue consisting of cells and a mineralized extracellular matrix, that is continuously&#x000a0;being remodeled&#x000a0;through&#x000a0;a dynamic process to maintain&#x000a0;structural integrity and shape.<xref ref-type="bibr" rid="article-26378.r10">[10]</xref>&#x000a0;Under normal physiologic&#x000a0;conditions, bone homeostasis is maintained through four&#x000a0;distinct&#x000a0;cell types: osteoblasts, which form bone; osteoclasts, which resorb bone; bone lining cells&#x000a0;(external surface-periosteal cells, internal surface-endosteal cells), which differentiate into osteoblasts; and osteocytes, or osteoblasts sequestered within lacunae that&#x000a0;function as mechanosensors and coordinators of the bone remodeling&#x000a0;process under the control of both local and systemic factors.<xref ref-type="bibr" rid="article-26378.r11">[11]</xref><xref ref-type="bibr" rid="article-26378.r12">[12]</xref>&#x000a0;Imbalance in this tightly coupled process can result in abnormal architecture&#x000a0;or function, leading to inadequate, excessive or ectopic calcification and resultant clinical manifestations such as osteoporosis, osteoporosis, or heterotopic ossification.<xref ref-type="bibr" rid="article-26378.r8">[8]</xref><xref ref-type="bibr" rid="article-26378.r13">[13]</xref></p>
        <p>Bone is a very complex and changeable organ, capable of influencing other organic structures and vice versa, as well as the immune system and systemic metabolic balance; the bone is influenced by multiple stimulations, internal (pressure, hydration, metabolism) and external (hormones, growth factors, mechanical pressures). The osteoblast can secrete several molecules in paracrine mode. For example, osteoblast-derived VEGF (vascular endothelial growth factor) can improve bone repair or during the bone development process.</p>
      </sec>
      <sec id="article-26378.s3" sec-type="Structure">
        <title>Structure</title>
        <p>Osteoblasts are cuboidal or polygonal cells that comprise only 4 to 6% of all bone cells and are predominately situated in matrix boundaries. These cells aggregate along bone surfaces, mostly&#x000a0;in the periosteum or endosteum,&#x000a0;and demonstrate the morphological characteristics of cells that synthesize an abundance of protein; this includes an&#x000a0;extensive&#x000a0;rough endoplasmic reticulum (RER), Golgi apparatus, numerous secretory vesicles, and mitochondria.<xref ref-type="bibr" rid="article-26378.r10">[10]</xref><xref ref-type="bibr" rid="article-26378.r11">[11]</xref></p>
        <p>Osteoblasts can secrete enzymes, pro-collagenases, which in contact with the matrix transform into collagenases by the action of osteoclasts; collagenase will be used by osteoclasts to disassemble collagen fibers.</p>
      </sec>
      <sec id="article-26378.s4" sec-type="Function">
        <title>Function</title>
        <p>Osteoblasts synthesize and secrete bone matrix to maintain the structural integrity and shape of bone. This process promotes bone formation, remodeling, and healing.<xref ref-type="bibr" rid="article-26378.r10">[10]</xref><xref ref-type="bibr" rid="article-26378.r14">[14]</xref></p>
      </sec>
      <sec id="article-26378.s5" sec-type="Tissue Preparation">
        <title>Tissue Preparation</title>
        <p>
<bold>Immunohistochemistry (IHC)</bold>
</p>
        <p>
<italic toggle="yes">Paraffin</italic>
</p>
        <p>A common practice to prepare bone tissue samples for IHC involves embedding decalcified tissue in paraffin. Of note, decalcifying bone changes&#x000a0;the overall morphology. Trabecular integrity is lost, and the bone cell environment is typically not&#x000a0;the same as&#x000a0;native mineralized bone.&#x000a0;</p>
        <p>
<italic toggle="yes">Methyl Methacrylate (MMA)</italic>
</p>
        <p>Non-decalcified bone tissue samples can embed in Methyl methacrylate (MMA) to better preserve the gross native bone morphology&#x000a0;with inorganic phosphates. Sectioning of bone samples embedded&#x000a0;with MMA is challenging, with conventional IHC then performed using either heat-induced antigen retrieval (typically for samples under 10 &#x003bc;m thick)&#x000a0;or microwave-based heat-induced retrieval. Both of these processes require a high degree of precision concerning temperature control to prevent the sample&#x000a0;from being inadvertently damaged.<xref ref-type="bibr" rid="article-26378.r15">[15]</xref></p>
      </sec>
      <sec id="article-26378.s6" sec-type="Histochemistry and Cytochemistry">
        <title>Histochemistry and Cytochemistry</title>
        <p>
<bold>Histology</bold>
</p>
        <p>Basic histological methods to identify osteoblasts include visualization of cell characteristics and location. Osteoblasts are cuboidal mononuclear cells located on bone surfaces.</p>
        <p>
<bold>Cytochemistry</bold>
</p>
        <p>Cytochemical methods to identify osteoblasts include&#x000a0;toluidine blue stain (also known as tolonium chloride), alkaline&#x000a0;phosphatase&#x000a0;(ALP) enzymatic stain, immunochemical markers, and fluorescent protein reporters.</p>
        <p>
<italic toggle="yes">Toluidine blue&#x000a0;</italic>
</p>
        <p>Toluidine blue is a basic thiazine&#x000a0;metachromatic dye used to identify osteoblasts in paraffin sections. The dye selectively stains acidic tissue rich in&#x000a0;nucleic acids, and other tissue components (sulfates, carboxylates, and phosphate radicals). Four adjacent&#x000a0;labeled cuboidal cells are required to categorize a surface as osteoblast populated.<xref ref-type="bibr" rid="article-26378.r16">[16]</xref></p>
        <p>
<italic toggle="yes">Alkaline Phosphatase (ALP) Enzymatic Stain</italic>
</p>
        <p>ALP is a membrane-bound metalloenzyme&#x000a0;that is instrumental in catalyzing the hydrolysis of phosphate monoesters. Depending on the site of tissue expression, one of four ALP glycoprotein isozymes is present. Specifically, bone contains a heat-labile isozyme that is a tissue non-specific alkaline phosphatase (TNSALP or liver/bone/kidney - L/B/K). Slight variations&#x000a0;exist between the L/B/K ALPs from different&#x000a0;tissues.<xref ref-type="bibr" rid="article-26378.r17">[17]</xref>&#x000a0;ALP is a&#x000a0;major enzymatic measure of osteoblastic activity and is more specific in&#x000a0;identifying osteoblasts.<xref ref-type="bibr" rid="article-26378.r18">[18]</xref><xref ref-type="bibr" rid="article-26378.r19">[19]</xref>&#x000a0;In vitro, ALP activity is expressed early in osteogenic lineage and in embryonic stem cells. However, alone it is not sufficient to designate&#x000a0;cells as mature osteoblasts.&#x000a0;Mineralization labels are often used, including alizarin complexone (red),&#x000a0;calcein (green), or demeclocycline (yellow).<xref ref-type="bibr" rid="article-26378.r9">[9]</xref><xref ref-type="bibr" rid="article-26378.r20">[20]</xref></p>
        <p>
<italic toggle="yes">Immunochemical Markers</italic>
</p>
        <p>Immunochemical markers proposed to be of utility&#x000a0;in identifying osteoblast precursors in either human or non-human models&#x000a0;include: osterix, nestin, alpha smooth muscle actin, connective tissue growth factor (CTGF) and paired related homeobox 1 (Prx1). Identifying pre-osteoblasts/osteoblasts include type I collagen, bone sialoprotein (BSP), osteocalcin (Oc), and osteopontin.<xref ref-type="bibr" rid="article-26378.r9">[9]</xref><xref ref-type="bibr" rid="article-26378.r21">[21]</xref></p>
        <p>
<italic toggle="yes">Fluorescent Protein Reporters</italic>
</p>
        <p>Fluorescent protein reporters have also proven useful and reliable for characterizing pre-osteoblasts (Col3.6) and mature osteoblasts (Col2.3, BSP, and Oc) in <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> applications. More recently,&#x000a0;Roeder et al. proposed a novel method for introducing visual transgenes into the osteoblast cell lineage in murine models to explore and identify different stages of osteogenic lineage maturation.<xref ref-type="bibr" rid="article-26378.r9">[9]</xref></p>
      </sec>
      <sec id="article-26378.s7" sec-type="Microscopy, Light&#x0000d;&#x0000a;">
        <title>Microscopy, Light
</title>
        <p>Mature osteoblasts are visible as a single layer of cuboidal or polygonal cells with strongly basophilic cytoplasm, eccentrically located nuclei, extensive RER, and a large Golgi complex (in negative image).<xref ref-type="bibr" rid="article-26378.r11">[11]</xref></p>
      </sec>
      <sec id="article-26378.s8" sec-type="Microscopy, Electron&#x0000d;&#x0000a;">
        <title>Microscopy, Electron
</title>
        <p>Due to the architectural complexity of bone, scanning, and transmission electron microscopy are frequently used to examine specimens, which enables the differentiation of mineralized and unmineralized components.&#x000a0;&#x000a0;</p>
        <p>
<italic toggle="yes">Scanning electron microscopy (SEM)</italic>
</p>
        <p>SEM affords&#x000a0;a high spatial resolution, relatively large depth, and&#x000a0;wide field of view without significant modification of the sample. SEM is typically used to identify composition and characterize the surfaces of samples. The strength of SEM in the topographical visualization of surfaces stems from the technique&#x000a0;of detecting electrons reflected off the sample.<xref ref-type="bibr" rid="article-26378.r22">[22]</xref>&#x000a0;</p>
        <p>When visualized, periosteal osteoblasts have elongated processes projecting from the cell surface.&#x000a0;Both the cell surface and processes have globular structures&#x000a0;with a diameter of approximately 0.1 microns. As&#x000a0;the periosteal surface is mineralized, the globules coalesce to form&#x000a0;nonhomogeneous mineralized spherules.&#x000a0;</p>
        <p>Endosteal osteoblasts have a similar general appearance, with fewer processes and no globular structures.<xref ref-type="bibr" rid="article-26378.r23">[23]</xref><xref ref-type="bibr" rid="article-26378.r24">[24]</xref>&#x000a0;</p>
        <p>
<italic toggle="yes">Transmission electron microscopy (TEM)</italic>
</p>
        <p>TEM primarily&#x000a0;provides the characterization of a sample's inner structures. In this&#x000a0;imagining&#x000a0;method, a beam of electrons is passed through a&#x000a0;sample, and the detected&#x000a0;contrast from electrons absorbed and scattered converts into an image.<xref ref-type="bibr" rid="article-26378.r25">[25]</xref>&#x000a0;</p>
        <p>TEM&#x000a0;has helped to reveal membrane-bound matrix vesicles within osteoblasts that appear to form through budding cell processes. Secretions from these osteoblast cell processes were observed to have&#x000a0;preformed membrane-bound vesicles resembling extracellular matrix vesicles.<xref ref-type="bibr" rid="article-26378.r23">[23]</xref><xref ref-type="bibr" rid="article-26378.r26">[26]</xref></p>
      </sec>
      <sec id="article-26378.s9" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>To fully understand the implication of physiologic disturbance of osteoblasts in various disease states, one must have a&#x000a0;perfunctory understanding of bone and the often-overlooked nuances of this dynamic&#x000a0;skeletal organ.</p>
        <p>
<bold>Overview of Osseous Components</bold>
</p>
        <p>
<italic toggle="yes">Bone (osseous tissue)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hard, dense connective tissue that gives structural support to the body</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Cortical (compact) bone</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Dense, outer cortex that supports and protects, the main store of calcium, accounts for 80% of bone mass, formed of osteons.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Cancellous (trabecular) bone</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Porous, highly vascular "spongy" internal tissue with a high surface area to volume ratio. Comprised of trabeculae. 20% bone mass, almost&#x000a0;10x the surface area of cortical bone. Red and yellow bone marrow fills in space between pores</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Periosteum</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Covers the external surface of&#x000a0;cortical&#x000a0;bone and is&#x000a0;a dense fibrous sheath containing osteoprogenitor cells.&#x000a0;An&#x000a0;exception is over articular surfaces, where articular cartilage is found. Periosteal cells are capable of becoming osteoblasts</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Endosteum</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Covers&#x000a0;innermost cortical bone&#x000a0;and is often only one cell thick. The endosteum lines the&#x000a0;medullary cavity. This cell layer also contains osteoprogenitor cells that can differentiate into osteoblasts</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Osteon (Haversian System)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The fundamental anatomical and functional unit of cortical bone; cylindrically arranged and typically parallel to the long axis. Area of remodeling in cortical bone</p>
          </list-item>
          <list-item>
            <p>Consists of concentric lamellae surrounding a central Haversian canal, which&#x000a0;permit blood vessels and nerves to travel within and supply the osteon</p>
          </list-item>
          <list-item>
            <p>Volkmann's canals are perpendicular perforating channels in lamellar bone that permit blood vessels and nerves to reach the Haversian canal from the periosteal and endosteal surface; these also interconnect the osteon&#x000a0;canals&#x000a0;</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Interstitial lamellae</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Remnants of partially resorbed osteons from previous remodeling</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Trabecula</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The main anatomical and functional unit of cancellous bone. Aligned towards mechanical load&#x000a0;distribution. Bone marrow is contained within the porosities created by the trabeculae&#x000a0;</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Bone Marrow</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Colloquially divided into "red" bone marrow (Medulla ossium rubra): active myeloid tissue where hemopoietic stem cells produce red blood cells; and "yellow" bone marrow (Medulla ossium flava):&#x000a0;hematopoietically inactive, mesenchymal stem cells (stroma) that accumulate lipids</p>
          </list-item>
          <list-item>
            <p>As individuals&#x000a0;age, the red marrow becomes yellow as the fat concentration increases. Yellow marrow can revert to red under physiologic stress requiring hemopoiesis.<xref ref-type="bibr" rid="article-26378.r27">[27]</xref><xref ref-type="bibr" rid="article-26378.r5">[5]</xref><xref ref-type="bibr" rid="article-26378.r28">[28]</xref><xref ref-type="bibr" rid="article-26378.r29">[29]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Physiology of Remodeling</bold>
</p>
        <p>Remodeling is a process orchestrated by bone multicellular units (BMUs), a term for aggregates of osteoblasts and osteoclasts that function sequentially to remodel bone. Estimates are that 1 million BMUs are active at any time. BMUs consist of a cutting cone of osteoclasts that resorb bone, and osteoblasts that subsequently fill in the resorption area. The process predominately divides into&#x000a0;four phases: activation, resorption, reversal, and formation.</p>
        <list list-type="bullet">
          <list-item>
            <p>Activation recruits osteoclasts</p>
          </list-item>
          <list-item>
            <p>Resorption osteoclasts "catabolize" or resorb bone</p>
          </list-item>
          <list-item>
            <p>In the reversal stage, osteoclasts undergo apoptosis and osteoblasts are recruited</p>
          </list-item>
          <list-item>
            <p>Osteoblasts then secrete a matrix in the Formation stage that mineralizes&#x000a0;<xref ref-type="bibr" rid="article-26378.r30">[30]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Location of Remodeling</bold>
</p>
        <p>Eighty percent of estimated bone remodeling activity has been demonstrated on cancellous bone surfaces. Cortical bone demonstrates intracortical remodeling in addition to remodeling on the periosteal and endocortical surfaces.<xref ref-type="bibr" rid="article-26378.r31">[31]</xref></p>
        <p>
<bold>Signaling</bold>
</p>
        <p>While not completely understood, bone and bone-forming cells exhibit many complex signaling mechanisms.</p>
        <p>MSCs&#x000a0;initially differentiate into osteoprogenitor cells, triggered by core-binding factor alpha-1 (CBFA1) or runt-related transcription factor 2 (RUNX2).<xref ref-type="bibr" rid="article-26378.r32">[32]</xref><xref ref-type="bibr" rid="article-26378.r33">[33]</xref><xref ref-type="bibr" rid="article-26378.r34">[34]</xref>&#x000a0;With RUNX2 activated, the cells become osteoprogenitor (or preosteoblast) cells. Under the influence&#x000a0;of bone morphogenic proteins (BMPs), insulin-like growth factor-1, -2 (IL-1, IL-2), Osterix, as well as other growth factors, the osteoprogenitor cells become osteoblasts.<xref ref-type="bibr" rid="article-26378.r33">[33]</xref><xref ref-type="bibr" rid="article-26378.r35">[35]</xref><xref ref-type="bibr" rid="article-26378.r36">[36]</xref><xref ref-type="bibr" rid="article-26378.r37">[37]</xref><xref ref-type="bibr" rid="article-26378.r38">[38]</xref>&#x000a0;</p>
        <p>Mature osteoblasts also produce receptor activator of nuclear factor-&#x003ba;B ligand (RANKL), osteoprotegerin (OPG), and macrophage colony-stimulating factor (M-CSF) which regulate further&#x000a0;osteoblast&#x000a0;differentiation into osteoclasts.<xref ref-type="bibr" rid="article-26378.r39">[39]</xref><xref ref-type="bibr" rid="article-26378.r40">[40]</xref></p>
        <p>Several signaling pathways that are imperative to maintaining a balance between osteoblast and osteoclasts include&#x000a0;WNT, BMP, PTH/PTHrP, Notch, and Hedgehog.<xref ref-type="bibr" rid="article-26378.r41">[41]</xref></p>
        <p>Furthermore, growth factors, and anabolic hormones (including fibroblast growth factor, insulin-like growth factor, interleukin-6, parathyroid hormone, estrogen, and calcitonin) exhibit&#x000a0;anti-apoptotic effects on osteoblasts. Tumor necrosis factor,&#x000a0;glucocorticoids, and bone morphogenic protein 2 induce apoptosis in osteoblasts.<xref ref-type="bibr" rid="article-26378.r10">[10]</xref></p>
        <p>
<bold>WNT/&#x003b2;-Catenin (Canonical WNT) Pathway</bold>
</p>
        <p>The cell-membrane Frizzled receptor and co-receptor&#x000a0;low-density lipoprotein receptor-related protein 5 (LRP5) are inactive in the absence of Wnt&#x000a0;ligands. Without Wnt,&#x000a0;&#x003b2;-catenin is phosphorylated by glycogen synthase kinase-3 (GSK-3), signaling it for&#x000a0;proteolysis&#x000a0;by ubiquitin-dependent proteases.&#x000a0;</p>
        <p>The Wnt pathway is activated when Wnt binds Frizzled and LRP5. GSK-3 downregulates. Inactivation of GSK-3 increases the accumulation of intracellular&#x000a0;&#x003b2;-catenin. &#x003b2;-catenin&#x000a0;subsequently translocates to the nucleus&#x000a0;and induces gene transcription that results in an increase in bone mass through a variety of different mechanisms.; this includes stem cell renewal,&#x000a0;preosteoblast&#x000a0;replication, osteoblastogenesis, and inhibiting osteoblast apoptosis. Other secreted inhibitors, such as&#x000a0;Dickkopf (Dkk) and Sclerostin (SOST), also can regulate signaling through the Wnt/Frizzled/LRP5 interaction.<xref ref-type="bibr" rid="article-26378.r30">[30]</xref><xref ref-type="bibr" rid="article-26378.r41">[41]</xref><xref ref-type="bibr" rid="article-26378.r42">[42]</xref><xref ref-type="bibr" rid="article-26378.r43">[43]</xref><xref ref-type="bibr" rid="article-26378.r44">[44]</xref></p>
        <p>Sclerostin, for example, is secreted from&#x000a0;terminally differentiated osteoblasts (osteocytes) embedded within the newly formed bone matrix. Sclerostin binds to and inhibits LRP5 from binding&#x000a0;to frizzled receptors. This process activates the Wnt pathway and increases bone production.<xref ref-type="bibr" rid="article-26378.r41">[41]</xref><xref ref-type="bibr" rid="article-26378.r43">[43]</xref></p>
        <p>
<bold>Parathyroid Hormone (PTH) &#x00026; Parathyroid Hormone Related Peptide (PTHrP) Pathways</bold>
</p>
        <p>PTH and PTHrP are distinct polypeptides that serve separate biological functions, though functioning through a common receptor -the&#x000a0;family B G-protein-coupled-receptor parathyroid hormone-1 receptor (PTH1R). PTH targets osteoblasts and renal tubular cells while PTHrP targets chondrocytes, osteoblasts, placental cells, skin, hair follicles, brain, and teeth. Notably, PTH functions to maintain calcium and phosphate homeostasis while PTHrP is involved in the development of the placenta, fetus, and bone.<xref ref-type="bibr" rid="article-26378.r45">[45]</xref></p>
        <p>PTH stimulates both resorption and formation of bone depending on the temporality of its exposure. Continuous elevation results in resorption, while intermittent elevation leads to osteoblast formation. Both effects appear to result from the modulation of PTH1R. Resorption may result&#x000a0;from increased RANKL synthesis and inhibiting&#x000a0;OPG mRNA expression, while the PTH induced mechanism for bone formation has not been completely elucidated.<xref ref-type="bibr" rid="article-26378.r46">[46]</xref><xref ref-type="bibr" rid="article-26378.r47">[47]</xref></p>
        <p>There have been suggestions that intermittent elevation of PTH results in the release of TGF-B from resorbing bone that, in the absence of stimulation, serves to recruit osteogenic progenitors. PTH is also an upstream regulator of Runx2. The cell cycle effect of PTH on Runx2 appears to be mediated&#x000a0;through MAP kinase ERK1/2 phosphorylation, activation of CREB/fos with JunD, resulting in the expression of IL-11 and suppression of Dkk as well as&#x000a0;cyclin D1 activity to increase bone formation.<xref ref-type="bibr" rid="article-26378.r8">[8]</xref><xref ref-type="bibr" rid="article-26378.r45">[45]</xref></p>
        <p>PTH&#x000a0;stimulates&#x000a0;osteoblasts to produce angiopoietin 1, a vascular growth factor&#x000a0;as well as&#x000a0;WNT co-receptor LRP6 and activates WNT signaling.<xref ref-type="bibr" rid="article-26378.r47">[47]</xref>&#x000a0;PTH also reduces SOST levels in bone, as does skeletal&#x000a0;loading.<xref ref-type="bibr" rid="article-26378.r46">[46]</xref></p>
        <p>Sodium-Hydrogen exchanger regulatory factor (NHERF) 1 also has been implicated in modulating PTH signaling.<xref ref-type="bibr" rid="article-26378.r48">[48]</xref>&#x000a0;The mechanisms, as mentioned earlier, could serve to contribute to skeletal manifestations of&#x000a0;individuals&#x000a0;with kidney or parathyroid disorders.<xref ref-type="bibr" rid="article-26378.r49">[49]</xref><xref ref-type="bibr" rid="article-26378.r50">[50]</xref><xref ref-type="bibr" rid="article-26378.r51">[51]</xref></p>
      </sec>
      <sec id="article-26378.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Osteoblasts are a significant contributor to the physiological&#x000a0;homeostasis of bone, and researchers have postulated their dysregulation as a potential factor in a broad spectrum of pathologic conditions, particularly conditions affecting the structural integrity of bone. Understanding osteoblasts requires a comparable concurrent cognizance of osteoclasts, their oppugnant cell, and the interactions between the cell types.<xref ref-type="bibr" rid="article-26378.r21">[21]</xref>&#x000a0;This topic has&#x000a0;volumes of publications comprising&#x000a0;numerous&#x000a0;scientific disciplines and can be extrapolated to many conditions. Select, frequently encountered&#x000a0;clinical conditions and biomarkers follow below to provide an overview, in no way representative of the true importance of osteoblasts.&#x000a0;</p>
        <p>
<bold>Osteoblast Markers</bold>
</p>
        <p>Many serum biomarkers of osteoblast function&#x000a0;exist. These include osteoprotegerin (OPG), receptor activator of nuclear factor kappa B ligand (RANKL), alkaline phosphatase (ALP), bone alkaline phosphatase (B-ALP), osteocalcin, procollagen type 1 carboxy-terminal propeptide (P1CP) and procollagen type 1 amino-terminal propeptide (P1NP).<xref ref-type="bibr" rid="article-26378.r21">[21]</xref><xref ref-type="bibr" rid="article-26378.r52">[52]</xref>&#x000a0;Seldomly are the majority&#x000a0;of these markers utilized&#x000a0;clinically to measure osteoblast function due to cost, analytical inconsistencies, and undetermined&#x000a0;clinical significance.<xref ref-type="bibr" rid="article-26378.r53">[53]</xref><xref ref-type="bibr" rid="article-26378.r54">[54]</xref><xref ref-type="bibr" rid="article-26378.r55">[55]</xref>&#x000a0;Osteocalcin is the most specific marker for osteoblastic activity.<xref ref-type="bibr" rid="article-26378.r38">[38]</xref></p>
        <p>
<bold>Alkaline Phosphatase</bold>
</p>
        <p>Serum alkaline phosphatases (ALPs) are probably the most common clinically encountered marker for osteoblastic activity. ALPs classify as either tissue-specific (intestine, placenta, and germinal tissue) or tissue-nonspecific (live, bone, and kidney). The tissue nonspecific ALPs are encoded by a single gene and are isoenzymes located on cell membranes&#x000a0;that catalyze the hydrolysis of organic phosphate esters.<xref ref-type="bibr" rid="article-26378.r56">[56]</xref>&#x000a0;A comprehensive metabolic panel (CMP) frequently measures tissue nonspecific&#x000a0;ALPs.&#x000a0;</p>
        <p>The clinical value&#x000a0;of ALP, as a marker for osteoblastic activity, on CMP is dictated by clinical context. While the most commonly encountered&#x000a0;elevation of&#x000a0;serum ALP is cholestatic liver disease, osteoblastic diseases of bone are also associated with increased serum ALP -such as metastatic adenocarcinoma of the prostate, osteogenic osteosarcoma, and early multiple myeloma.<xref ref-type="bibr" rid="article-26378.r56">[56]</xref><xref ref-type="bibr" rid="article-26378.r57">[57]</xref><xref ref-type="bibr" rid="article-26378.r58">[58]</xref><xref ref-type="bibr" rid="article-26378.r59">[59]</xref><xref ref-type="bibr" rid="article-26378.r60">[60]</xref>&#x000a0;Patients with healing fractures and metabolic bone disease (including rickets, osteomalacia, osteopetrosis, or Paget's Disease of bone) can also have an elevated ALP.<xref ref-type="bibr" rid="article-26378.r57">[57]</xref><xref ref-type="bibr" rid="article-26378.r61">[61]</xref><xref ref-type="bibr" rid="article-26378.r62">[62]</xref>&#x000a0;It is important to note that osteoclastic processes will not directly affect ALP.&#x000a0;</p>
        <p>Decreased levels of serum alkaline phosphatase are observable in conditions affecting osteoblastic activity such as hypophosphatasia and cleidocranial dysplasia.<xref ref-type="bibr" rid="article-26378.r63">[63]</xref><xref ref-type="bibr" rid="article-26378.r64">[64]</xref></p>
        <p>Alkaline phosphatase immunohistochemistry is also utilized in pathology&#x000a0;to demonstrate osteoblastic activity. ALP IHC staining contributes to aid in diagnosing osteosarcoma and other primary bone tumors, such as giant cell tumor of bone.<xref ref-type="bibr" rid="article-26378.r65">[65]</xref><xref ref-type="bibr" rid="article-26378.r66">[66]</xref></p>
        <p>
<bold>Development &#x00026; Peak Bone Mass&#x000a0;</bold>
</p>
        <p>Osseous development&#x000a0;follows a predictable, stepwise progression&#x000a0;of formation, beginning in&#x000a0;the sixth to seventh week of embryonic development until adulthood.<xref ref-type="bibr" rid="article-26378.r67">[67]</xref>&#x000a0;Alkaline phosphatase is commonly&#x000a0;elevated during these periods of bone growth and has a strong correlation to conventional bone maturity factors.<xref ref-type="bibr" rid="article-26378.r68">[68]</xref><xref ref-type="bibr" rid="article-26378.r69">[69]</xref><xref ref-type="bibr" rid="article-26378.r56">[56]</xref>&#x000a0;During pubertal maturation, bone size increases while volumetric density remains relatively constant.&#x000a0;Bone mass and strength, or peak bone mass, is achieved at the end of the growth process with the&#x000a0;closure of all ossification centers.<xref ref-type="bibr" rid="article-26378.r70">[70]</xref>&#x000a0;The exact age when individuals achieve peak bone mass (PBM) is a point of dispute in the literature. Consensus data from most studies estimate that PBM is achieved between an individual's early twenties and thirties.&#x000a0;Bone mass accumulation&#x000a0;varies not only&#x000a0;between males&#x000a0;and females but also between races as well. Non-modifiable factors, such as genetics, and modifiable risk factors, including nutrition, physical activity, and smoking status, also account for this variation.<xref ref-type="bibr" rid="article-26378.r71">[71]</xref>&#x000a0;Even following the attainment of peak bone mass, bone continues&#x000a0;to undergo remodeling.&#x000a0;Bone mass will&#x000a0;remain&#x000a0;stable for up to two decades.<xref ref-type="bibr" rid="article-26378.r30">[30]</xref></p>
        <p>Patients need to understand that bone is a living organ, continually remodeling. The importance of remodeling includes replacing damaged bone to maintain mechanical strength and calcium homeostasis.&#x000a0;Wolff's law states that bone adapts and remodels as a&#x000a0;response to stress from mechanical forces, changing its architecture.<xref ref-type="bibr" rid="article-26378.r72">[72]</xref>&#x000a0;Wolff's law also has implications in a maladaptive response that contributes to periarticular bone formation in association with osteoarthritis.<xref ref-type="bibr" rid="article-26378.r73">[73]</xref>&#x000a0;This process has been hypothesized as the mechanism forming&#x000a0;osteophytes.&#x000a0;</p>
        <p>
<bold>Aging&#x000a0;</bold>
</p>
        <p>As humans age, various factors such as reduced mechanical loading and endocrine dysfunction&#x000a0;contribute to an imbalance between bone formation and bone resorption. This dysfunction results in an alteration of&#x000a0;bone quantity and quality.&#x000a0;The importance of cortical remodeling also increases as cancellous bone is lost; remodeling in both compartments increases.</p>
        <p>Waning vitamin D production and decreasing calcium absorption exacerbate the incongruity between preserving bone strength and providing the body with calcium, which manifests as secondary hyperparathyroidism, maintaining serum calcium levels at the expense of bone resorption.&#x000a0;</p>
        <p>Postmenopausal women and older men are particularly at-risk populations. The&#x000a0;balance between resorption and formation becomes&#x000a0;negative, leading to irreversible trabecular thinning and loss, as well as cortical thinning.<xref ref-type="bibr" rid="article-26378.r30">[30]</xref><xref ref-type="bibr" rid="article-26378.r74">[74]</xref><xref ref-type="bibr" rid="article-26378.r75">[75]</xref>&#x000a0;</p>
        <p>
<bold>Osteoporosis</bold>
</p>
        <p>Osteoporosis is the most&#x000a0;common disease of bone and a major public health concern.&#x000a0;Osteoporotic bone exhibits decreased mass, deteriorated tissue, and disrupted&#x000a0;architecture that results in compromised&#x000a0;strength.<xref ref-type="bibr" rid="article-26378.r76">[76]</xref><xref ref-type="bibr" rid="article-26378.r77">[77]</xref><xref ref-type="bibr" rid="article-26378.r78">[78]</xref>&#x000a0;In short, resorption becomes&#x000a0;greater than formation.&#x000a0;</p>
        <p>The diagnosis is by measuring&#x000a0;bone mineral density (BMD) with a dual-energy X-ray absorptiometry (DEXA) scan or after a vertebral or hip fragility fracture in the absence of significant trauma.&#x000a0;Two methods serve to calculate BMD.</p>
        <list list-type="bullet">
          <list-item>
            <p>T-score:
<list list-type="bullet"><list-item><p>Comparison to healthy, young, sex-matched individuals</p></list-item><list-item><p>A score of less than -2.5 standard deviations (SDs) below average&#x000a0;defines osteoporosis, as defined by the WHO&#x000a0;<xref ref-type="bibr" rid="article-26378.r79">[79]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Z-score:
<list list-type="bullet"><list-item><p>Comparison to persons&#x000a0;of same age and sex</p></list-item><list-item><p>A score of less than -2.5 SDs is suspicious for a secondary cause of osteoporosis</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Osteoporosis divides into two types:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary Osteoporosis
<list list-type="bullet"><list-item><p>Postmenopausal (involutional osteoporosis Type I): deficiency of estrogen, primarily affecting trabecular bone</p></list-item><list-item><p>Senile (involutional osteoporosis Type II): decrease bone mass secondary to the aging of both cortical and trabecular bone</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Secondary Osteoporosis
<list list-type="bullet"><list-item><p>Due to an extensive array of factors including but not limited to: lifestyle, genetics, autoimmune disease, rheumatologic disease, endocrine, gastrointestinal, hematological, or neurological disorder.<xref ref-type="bibr" rid="article-26378.r76">[76]</xref><xref ref-type="bibr" rid="article-26378.r80">[80]</xref><xref ref-type="bibr" rid="article-26378.r81">[81]</xref>&#x000a0;Endocrine disorders are the most common cause of secondary osteopenia in men and women.<xref ref-type="bibr" rid="article-26378.r82">[82]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Estrogen insufficiency especially predisposes postmenopausal&#x000a0;women and older men to osteoporosis through a variety of mechanisms, including increasing osteocyte apoptosis. While incompletely understood,&#x000a0;this has been postulated to be partially due to dysregulation between receptor activator of nuclear factor-&#x003ba;B ligand (RANKL), receptor activator of nuclear factor-&#x003ba;B (RANK) and osteoprotegerin (OPG), a decoy receptor the neutralizes RANKL. The&#x000a0;RANK/RANKL/OPG pathway is pivotal in osteoclast activation, and the dysregulation between&#x000a0;osteoclastic and osteoblastic activity partially stems from the biological effect of estrogen on&#x000a0;this mechanism.&#x000a0;</p>
        <p>Specifically, estrogen has demonstrated to modulate&#x000a0;RANKL, a membrane-bound protein secreted by osteoblasts, critical for osteoclast differentiation (through its&#x000a0;binding to RANK), activation, and survival. Estrogen also upregulates&#x000a0;OPG expression, which inhibits osteoclastogenesis.&#x000a0;RANK and&#x000a0;M-CSF, a factor that increases bone resorption, have been demonstrated to be&#x000a0;downregulated by estrogen.&#x000a0;Estrogen directly protects bone by preventing: osteocyte apoptosis, osteoclast survival (through TGF-B), and osteoblast apoptosis (through the Fas ligand). This is in opposition to&#x000a0;1,25(OH)2D3, PTH/PGE2, and interleukin (IL)-11, which&#x000a0;induce RANKL expression.<xref ref-type="bibr" rid="article-26378.r83">[83]</xref><xref ref-type="bibr" rid="article-26378.r84">[84]</xref><xref ref-type="bibr" rid="article-26378.r85">[85]</xref><xref ref-type="bibr" rid="article-26378.r86">[86]</xref><xref ref-type="bibr" rid="article-26378.r87">[87]</xref><xref ref-type="bibr" rid="article-26378.r88">[88]</xref><xref ref-type="bibr" rid="article-26378.r89">[89]</xref></p>
        <p>The North American Menopause Society&#x000a0;recommends that all postmenopausal women, regardless of BMD, observe the following recommendations <xref ref-type="bibr" rid="article-26378.r79">[79]</xref><xref ref-type="bibr" rid="article-26378.r90">[90]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Recommended daily allowance calcium&#x000a0;(female)
<list list-type="bullet"><list-item><p>1,000 mg/d - age 19&#x000a0;to 50</p></list-item><list-item><p>1,200 mg/d - 50+</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Recommended daily allowance calcium (male)
<list list-type="bullet"><list-item><p>1,000 mg/d - age 19&#x000a0;to 70</p></list-item><list-item><p>1,200 mg/d - 70+</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Recommended daily allowance vitamin D (male and female)
<list list-type="bullet"><list-item><p>600 IU/d - age 19&#x000a0;to 70</p></list-item><list-item><p>800 IU/d - 70+</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Commonly prescribed medications for osteoporotic bone disease includes recombinant parathyroid hormone [PTH(1-34)] to stimulate osteoblasts and antiresorptive agents.<xref ref-type="bibr" rid="article-26378.r79">[79]</xref><xref ref-type="bibr" rid="article-26378.r91">[91]</xref><xref ref-type="bibr" rid="article-26378.r92">[92]</xref><xref ref-type="bibr" rid="article-26378.r93">[93]</xref><xref ref-type="bibr" rid="article-26378.r94">[94]</xref><xref ref-type="bibr" rid="article-26378.r79">[79]</xref><xref ref-type="bibr" rid="article-26378.r95">[95]</xref><xref ref-type="bibr" rid="article-26378.r96">[96]</xref></p>
        <p>
<bold>Osteoarthritis</bold>
</p>
        <p>Recent evidence from Maruotti et al. suggests that while the pathogenesis of osteoarthritis (OA) is still poorly understood, osteoblastic dysregulation could&#x000a0;play a&#x000a0;substantial role. Abnormal expression of OPG and RANKL has been observed in osteoblasts from patients with osteoarthritic changes. Various transcription factors, growth factors, PGE2, and IL-6, have also been demonstrated to be produced in aberrant&#x000a0;quantities&#x000a0;by osteoarthritis osteoblasts, possibly contributing to the pathogenesis&#x000a0;of OA.<xref ref-type="bibr" rid="article-26378.r97">[97]</xref></p>
        <p>
<bold>PTHrP and Malignancy&#x000a0;</bold>
</p>
        <p>PTHrP is a known mediator of malignancy-induced hypercalcemia (or humoral hypercalcemia of malignancy - HHM).<xref ref-type="bibr" rid="article-26378.r98">[98]</xref>&#x000a0;The substantial, sustained&#x000a0;exposure of PTHrP has been proposed&#x000a0;to stimulate bone metastasis and&#x000a0;increase RANKL synthesis,&#x000a0;subsequently contributing&#x000a0;to osteolytic&#x000a0;lesions.<xref ref-type="bibr" rid="article-26378.r99">[99]</xref><xref ref-type="bibr" rid="article-26378.r100">[100]</xref><xref ref-type="bibr" rid="article-26378.r101">[101]</xref><xref ref-type="bibr" rid="article-26378.r102">[102]</xref><xref ref-type="bibr" rid="article-26378.r103">[103]</xref>&#x000a0;The atmospherics of the mechanism through which PTHrP exerts its devastating&#x000a0;biochemical influence in this context are&#x000a0;functionally&#x000a0;commensurate&#x000a0;to that of PTH on PTH1R.<xref ref-type="bibr" rid="article-26378.r104">[104]</xref><xref ref-type="bibr" rid="article-26378.r105">[105]</xref><xref ref-type="bibr" rid="article-26378.r106">[106]</xref></p>
        <p>
<bold>Medications</bold>
</p>
        <p>Medications such as calcitonin, recombinant PTH, selective estrogen receptor modulators, and human monoclonal antibodies that bind RANKL can either directly or indirectly modulate osteoblast function. These medications are frequently used in the management of osteoporosis and other conditions.<xref ref-type="bibr" rid="article-26378.r76">[76]</xref><xref ref-type="bibr" rid="article-26378.r107">[107]</xref><xref ref-type="bibr" rid="article-26378.r108">[108]</xref></p>
        <p>
<bold>Glucocorticosteroids</bold>
</p>
        <p>Glucocorticoid excess has been&#x000a0;established to decrease bone mineral density by reducing bone formation and increasing resorption. Glucocorticoids&#x000a0;inhibit osteoblastogenesis, increase osteoblast apoptosis, and decrease osteoclast apoptosis.<xref ref-type="bibr" rid="article-26378.r109">[109]</xref><xref ref-type="bibr" rid="article-26378.r110">[110]</xref></p>
      </sec>
      <sec id="article-26378.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26378&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26378">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26378/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26378">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26378.s12">
        <fig id="article-26378.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Osteoclastogenesis. Bone-resorbing osteoclasts originate from hemopoietic cells of the monocyte&#x02013;macrophage lineage under the control of bone-forming osteoblasts. Illustration includes RANKL, the receptor activator of NF-&#x003ba;B ligand; M-CSF, macrophage colony-stimulating factor; and OPG, osteoprotegerin. Contributed by KE Doyle, MEd</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="osteoclastogenesisnoletters-2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-26378.s13">
        <fig id="article-26378.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Bone, Part of the growing edge of the developing parietal bone of fetal cat, Osteoblasts Henry Vandyke Carter, Public Domain, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Gray078" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-26378.s14">
        <fig id="article-26378.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Bone, Osteoblasts and osteoclasts on trabecula of lower jaw of calf embryo Henry Vandyke Carter, Public Domain, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Gray081" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26378.s15">
        <title>References</title>
        <ref id="article-26378.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakayamada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Osteoblasts and osteoclasts in bone remodeling and inflammation.</article-title>
            <source>Curr Drug Targets Inflamm Allergy</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>325</fpage>
            <page-range>325-8</page-range>
            <pub-id pub-id-type="pmid">16101541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morello</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta and therapeutics.</article-title>
            <source>Matrix Biol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>71-72</volume>
            <fpage>294</fpage>
            <page-range>294-312</page-range>
            <pub-id pub-id-type="pmid">29540309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.</article-title>
            <source>Curr Chem Biol</source>
            <year>2009</year>
            <month>May</month>
            <day>01</day>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-196</page-range>
            <pub-id pub-id-type="pmid">20161446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bou Assaf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zibara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fayyad-Kazan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Al-Nemer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cordahi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khairallah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Badran</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Berb&#x000e9;ri</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Healing of Bone Defects in Pig's Femur Using Mesenchymal Cells Originated from the Sinus Membrane with Different Scaffolds.</article-title>
            <source>Stem Cells Int</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>4185942</fpage>
            <pub-id pub-id-type="pmid">31662765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le</surname>
                <given-names>BQ</given-names>
              </name>
              <name>
                <surname>Nurcombe</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cool</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>van Blitterswijk</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>LaPointe</surname>
                <given-names>VLS</given-names>
              </name>
            </person-group>
            <article-title>The Components of Bone and What They Can Teach Us about Regeneration.</article-title>
            <source>Materials (Basel)</source>
            <year>2017</year>
            <month>Dec</month>
            <day>22</day>
            <volume>11</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29271933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ottewell</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>The role of osteoblasts in bone metastasis.</article-title>
            <source>J Bone Oncol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>124</fpage>
            <page-range>124-127</page-range>
            <pub-id pub-id-type="pmid">27761372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsuo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Irie</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Osteoclast-osteoblast communication.</article-title>
            <source>Arch Biochem Biophys</source>
            <year>2008</year>
            <month>May</month>
            <day>15</day>
            <volume>473</volume>
            <issue>2</issue>
            <fpage>201</fpage>
            <page-range>201-9</page-range>
            <pub-id pub-id-type="pmid">18406338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rutkovskiy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stensl&#x000f8;kken</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Vaage</surname>
                <given-names>IJ</given-names>
              </name>
            </person-group>
            <article-title>Osteoblast Differentiation at a Glance.</article-title>
            <source>Med Sci Monit Basic Res</source>
            <year>2016</year>
            <month>Sep</month>
            <day>26</day>
            <volume>22</volume>
            <fpage>95</fpage>
            <page-range>95-106</page-range>
            <pub-id pub-id-type="pmid">27667570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roeder</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Matthews</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Kalajzic</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Visual reporters for study of the osteoblast lineage.</article-title>
            <source>Bone</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>92</volume>
            <fpage>189</fpage>
            <page-range>189-195</page-range>
            <pub-id pub-id-type="pmid">27616604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenberg</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Soudry</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Osteoblasts in bone physiology-mini review.</article-title>
            <source>Rambam Maimonides Med J</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>e0013</fpage>
            <pub-id pub-id-type="pmid">23908837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Florencio-Silva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sasso</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Sasso-Cerri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sim&#x000f5;es</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cerri</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells.</article-title>
            <source>Biomed Res Int</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>421746</fpage>
            <pub-id pub-id-type="pmid">26247020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marie</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Cohen-Solal</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The Expanding Life and Functions of Osteogenic Cells: From Simple Bone-Making Cells to Multifunctional Cells and Beyond.</article-title>
            <source>J Bone Miner Res</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-210</page-range>
            <pub-id pub-id-type="pmid">29206311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Duan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Osteoblast-osteoclast interactions.</article-title>
            <source>Connect Tissue Res</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-107</page-range>
            <pub-id pub-id-type="pmid">28324674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czekanska</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Stoddart</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>In search of an osteoblast cell model for in vitro research.</article-title>
            <source>Eur Cell Mater</source>
            <year>2012</year>
            <month>Jul</month>
            <day>09</day>
            <volume>24</volume>
            <fpage>1</fpage>
            <page-range>1-17</page-range>
            <pub-id pub-id-type="pmid">22777949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akkiraju</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bonor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nohe</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An Improved Immunostaining and Imaging Methodology to Determine Cell and Protein Distributions within the Bone Environment.</article-title>
            <source>J Histochem Cytochem</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>168</fpage>
            <page-range>168-78</page-range>
            <pub-id pub-id-type="pmid">26718242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sridharan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Toluidine blue: A review of its chemistry and clinical utility.</article-title>
            <source>J Oral Maxillofac Pathol</source>
            <year>2012</year>
            <month>May</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-5</page-range>
            <pub-id pub-id-type="pmid">22923899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Pal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Alkaline phosphatase: an overview.</article-title>
            <source>Indian J Clin Biochem</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>269</fpage>
            <page-range>269-78</page-range>
            <pub-id pub-id-type="pmid">24966474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cosby</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Troiano</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Kacena</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>The Effects of Storage Conditions on the Preservation of Enzymatic Activity in Bone.</article-title>
            <source>J Histotechnol</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>169</fpage>
            <page-range>169-173</page-range>
            <pub-id pub-id-type="pmid">20686670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Graca</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Messick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Lorimier</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors.</article-title>
            <source>Vet Pathol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-5</page-range>
            <pub-id pub-id-type="pmid">15753469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Byun</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Ro</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>UK</given-names>
              </name>
            </person-group>
            <article-title>The effect of biomechanical stimulation on osteoblast differentiation of human jaw periosteum-derived stem cells.</article-title>
            <source>Maxillofac Plast Reconstr Surg</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <pub-id pub-id-type="pmid">28303237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r21">
          <label>21</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Rowe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Koller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Physiology, Bone Remodeling</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>3</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">29763038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fischer</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hoyt</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Dorward</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Scanning electron microscopy.</article-title>
            <source>Curr Protoc Microbiol</source>
            <year>2012</year>
            <month>May</month>
            <volume>Chapter 2</volume>
            <fpage>Unit 2B.2.</fpage>
            <pub-id pub-id-type="pmid">22549162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ornoy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Atkin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ultrastructural studies on the origin and structure of matrix vesicles in bone of young rats.</article-title>
            <source>Acta Anat (Basel)</source>
            <year>1980</year>
            <volume>106</volume>
            <issue>4</issue>
            <fpage>450</fpage>
            <page-range>450-61</page-range>
            <pub-id pub-id-type="pmid">7386166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Ruscs&#x000e1;k</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Palmquist</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>50 years of scanning electron microscopy of bone-a comprehensive overview of the important discoveries made and insights gained into bone material properties in health, disease, and taphonomy.</article-title>
            <source>Bone Res</source>
            <year>2019</year>
            <volume>7</volume>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">31123620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meehl</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>O'Toole</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Giddings</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Conventional transmission electron microscopy.</article-title>
            <source>Mol Biol Cell</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>319</fpage>
            <page-range>319-23</page-range>
            <pub-id pub-id-type="pmid">24482357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bottini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mebarek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Strzelecka-Kiliszek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bozycki</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sim&#x000e3;o</surname>
                <given-names>AMS</given-names>
              </name>
              <name>
                <surname>Bolean</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciancaglini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pikula</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Pikula</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Magne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Volkmann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hanein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mill&#x000e1;n</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Buchet</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Matrix vesicles from chondrocytes and osteoblasts: Their biogenesis, properties, functions and biomimetic models.</article-title>
            <source>Biochim Biophys Acta Gen Subj</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>1862</volume>
            <issue>3</issue>
            <fpage>532</fpage>
            <page-range>532-546</page-range>
            <pub-id pub-id-type="pmid">29108957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clarke</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Normal bone anatomy and physiology.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>3 Suppl 3</volume>
            <issue>Suppl 3</issue>
            <fpage>S131</fpage>
            <page-range>S131-9</page-range>
            <pub-id pub-id-type="pmid">18988698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma&#x00142;kiewicz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dziedzic</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bone marrow reconversion - imaging of physiological changes in bone marrow.</article-title>
            <source>Pol J Radiol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>77</volume>
            <issue>4</issue>
            <fpage>45</fpage>
            <page-range>45-50</page-range>
            <pub-id pub-id-type="pmid">23269936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gurevitch</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Slavin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Conversion of red bone marrow into yellow - Cause and mechanisms.</article-title>
            <source>Med Hypotheses</source>
            <year>2007</year>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>531</fpage>
            <page-range>531-6</page-range>
            <pub-id pub-id-type="pmid">17433565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langdahl</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dempster</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis.</article-title>
            <source>Ther Adv Musculoskelet Dis</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>225</fpage>
            <page-range>225-235</page-range>
            <pub-id pub-id-type="pmid">28255336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delgado-Calle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bellido</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Osteocytes and Skeletal Pathophysiology.</article-title>
            <source>Curr Mol Biol Rep</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>157</fpage>
            <page-range>157-167</page-range>
            <pub-id pub-id-type="pmid">26693137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caetano-Lopes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Canh&#x000e3;o</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Osteoblasts and bone formation.</article-title>
            <source>Acta Reumatol Port</source>
            <year>2007</year>
            <season>Apr-Jun</season>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-10</page-range>
            <pub-id pub-id-type="pmid">17572649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinha</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Genetic and molecular control of osterix in skeletal formation.</article-title>
            <source>J Cell Biochem</source>
            <year>2013</year>
            <month>May</month>
            <volume>114</volume>
            <issue>5</issue>
            <fpage>975</fpage>
            <page-range>975-84</page-range>
            <pub-id pub-id-type="pmid">23225263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ducy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Geoffroy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ridall</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Karsenty</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.</article-title>
            <source>Cell</source>
            <year>1997</year>
            <month>May</month>
            <day>30</day>
            <volume>89</volume>
            <issue>5</issue>
            <fpage>747</fpage>
            <page-range>747-54</page-range>
            <pub-id pub-id-type="pmid">9182762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karsenty</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The genetic transformation of bone biology.</article-title>
            <source>Genes Dev</source>
            <year>1999</year>
            <month>Dec</month>
            <day>01</day>
            <volume>13</volume>
            <issue>23</issue>
            <fpage>3037</fpage>
            <page-range>3037-51</page-range>
            <pub-id pub-id-type="pmid">10601030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Heersche</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone.</article-title>
            <source>Bone</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>785</fpage>
            <page-range>785-94</page-range>
            <pub-id pub-id-type="pmid">11113389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellido</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Borba</surname>
                <given-names>VZ</given-names>
              </name>
              <name>
                <surname>Roberson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Manolagas</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.</article-title>
            <source>Endocrinology</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>138</volume>
            <issue>9</issue>
            <fpage>3666</fpage>
            <page-range>3666-76</page-range>
            <pub-id pub-id-type="pmid">9275051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>YP</given-names>
              </name>
            </person-group>
            <article-title>Signaling and transcriptional regulation in osteoblast commitment and differentiation.</article-title>
            <source>Front Biosci</source>
            <year>2007</year>
            <month>May</month>
            <day>01</day>
            <volume>12</volume>
            <fpage>3068</fpage>
            <page-range>3068-92</page-range>
            <pub-id pub-id-type="pmid">17485283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamashita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Udagawa</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>New roles of osteoblasts involved in osteoclast differentiation.</article-title>
            <source>World J Orthop</source>
            <year>2012</year>
            <month>Nov</month>
            <day>18</day>
            <volume>3</volume>
            <issue>11</issue>
            <fpage>175</fpage>
            <page-range>175-81</page-range>
            <pub-id pub-id-type="pmid">23330072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Teitelbaum</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Osteoclasts: New Insights.</article-title>
            <source>Bone Res</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-26</page-range>
            <pub-id pub-id-type="pmid">26273491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ethen</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>BO</given-names>
              </name>
            </person-group>
            <article-title>WNT signaling in bone development and homeostasis.</article-title>
            <source>Wiley Interdiscip Rev Dev Biol</source>
            <year>2014</year>
            <season>Nov-Dec</season>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>489</fpage>
            <page-range>489-500</page-range>
            <pub-id pub-id-type="pmid">25270716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joiner</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Ke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>BO</given-names>
              </name>
            </person-group>
            <article-title>LRP5 and LRP6 in development and disease.</article-title>
            <source>Trends Endocrinol Metab</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-9</page-range>
            <pub-id pub-id-type="pmid">23245947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishnan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Macdougald</surname>
                <given-names>OA</given-names>
              </name>
            </person-group>
            <article-title>Regulation of bone mass by Wnt signaling.</article-title>
            <source>J Clin Invest</source>
            <year>2006</year>
            <month>May</month>
            <volume>116</volume>
            <issue>5</issue>
            <fpage>1202</fpage>
            <page-range>1202-9</page-range>
            <pub-id pub-id-type="pmid">16670761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacDonald</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Tamai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Wnt/beta-catenin signaling: components, mechanisms, and diseases.</article-title>
            <source>Dev Cell</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-26</page-range>
            <pub-id pub-id-type="pmid">19619488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Datta</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Abou-Samra</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>PTH and PTHrP signaling in osteoblasts.</article-title>
            <source>Cell Signal</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>8</issue>
            <fpage>1245</fpage>
            <page-range>1245-54</page-range>
            <pub-id pub-id-type="pmid">19249350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wein</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Parathyroid Hormone Signaling in Osteocytes.</article-title>
            <source>JBMR Plus</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-30</page-range>
            <pub-id pub-id-type="pmid">30283888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jilka</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Bartell</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Manolagas</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.</article-title>
            <source>J Bone Miner Res</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>11</issue>
            <fpage>2427</fpage>
            <page-range>2427-37</page-range>
            <pub-id pub-id-type="pmid">20533302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Partridge</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Parathyroid hormone signaling in bone and kidney.</article-title>
            <source>Curr Opin Nephrol Hypertens</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>298</fpage>
            <page-range>298-302</page-range>
            <pub-id pub-id-type="pmid">19395963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Damasiewicz</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Nickolas</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Rethinking Bone Disease in Kidney Disease.</article-title>
            <source>JBMR Plus</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>2</volume>
            <issue>6</issue>
            <fpage>309</fpage>
            <page-range>309-322</page-range>
            <pub-id pub-id-type="pmid">30460334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Chronic kidney disease and the skeleton.</article-title>
            <source>Bone Res</source>
            <year>2014</year>
            <volume>2</volume>
            <fpage>14044</fpage>
            <pub-id pub-id-type="pmid">26273531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bandeira</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cusano</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Cassibba</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Bilezikian</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Bone disease in primary hyperparathyroidism.</article-title>
            <source>Arq Bras Endocrinol Metabol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>553</fpage>
            <page-range>553-61</page-range>
            <pub-id pub-id-type="pmid">25166047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wheater</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Elshahaly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tuck</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Datta</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>van Laar</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The clinical utility of bone marker measurements in osteoporosis.</article-title>
            <source>J Transl Med</source>
            <year>2013</year>
            <month>Aug</month>
            <day>29</day>
            <volume>11</volume>
            <fpage>201</fpage>
            <pub-id pub-id-type="pmid">23984630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rogers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eastell</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>90</volume>
            <issue>11</issue>
            <fpage>6323</fpage>
            <page-range>6323-31</page-range>
            <pub-id pub-id-type="pmid">16105967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattoa</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Laboratory aspects and clinical utility of bone turnover markers.</article-title>
            <source>EJIFCC</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>117</fpage>
            <page-range>117-128</page-range>
            <pub-id pub-id-type="pmid">30050395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camozzi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tossi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simoni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pagani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Francucci</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Moro</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Role of biochemical markers of bone remodeling in clinical practice.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2007</year>
            <volume>30</volume>
            <issue>6 Suppl</issue>
            <fpage>13</fpage>
            <page-range>13-7</page-range>
            <pub-id pub-id-type="pmid">17721068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r56">
          <label>56</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Lowe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sanvictores</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zubair</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Alkaline Phosphatase</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>10</month>
            <day>29</day>
            <pub-id pub-id-type="pmid">29083622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r57">
          <label>57</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Vroon</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Israili</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <chapter-title>Alkaline Phosphatase and Gamma Glutamyltransferase</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Walker</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Hurst</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <source>Clinical Methods: The History, Physical, and Laboratory Examinations</source>
            <edition>3rd</edition>
            <publisher-name>Butterworths</publisher-name>
            <publisher-loc>Boston</publisher-loc>
            <year>1990</year>
            <pub-id pub-id-type="pmid">21250047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bataille</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chappard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Marcelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dessauw</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Baldet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sany</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alexandre</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.</article-title>
            <source>J Clin Invest</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>88</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-6</page-range>
            <pub-id pub-id-type="pmid">2056131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siddique</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kowdley</surname>
                <given-names>KV</given-names>
              </name>
            </person-group>
            <article-title>Approach to a patient with elevated serum alkaline phosphatase.</article-title>
            <source>Clin Liver Dis</source>
            <year>2012</year>
            <month>May</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-229</page-range>
            <pub-id pub-id-type="pmid">22541695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Clinical significance of osteoblast precursors and osteoclast precursors in earlier diagnosis and monitoring of myeloma bone disease.</article-title>
            <source>Ann Hematol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>95</volume>
            <issue>7</issue>
            <fpage>1099</fpage>
            <page-range>1099-106</page-range>
            <pub-id pub-id-type="pmid">27118542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Disorders of bone remodeling.</article-title>
            <source>Annu Rev Pathol</source>
            <year>2011</year>
            <volume>6</volume>
            <fpage>121</fpage>
            <page-range>121-45</page-range>
            <pub-id pub-id-type="pmid">20936937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smellie</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Forth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ryder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Galloway</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>ID</given-names>
              </name>
            </person-group>
            <article-title>Best practice in primary care pathology: review 5.</article-title>
            <source>J Clin Pathol</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>59</volume>
            <issue>12</issue>
            <fpage>1229</fpage>
            <page-range>1229-37</page-range>
            <pub-id pub-id-type="pmid">16644875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deeb</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elfatih</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Could Alerting Physicians for Low Alkaline Phosphatase Levels Be Helpful in Early Diagnosis of Hypophosphatasia?</article-title>
            <source>J Clin Res Pediatr Endocrinol</source>
            <year>2018</year>
            <month>Mar</month>
            <day>01</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-24</page-range>
            <pub-id pub-id-type="pmid">28766503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morava</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>K&#x000e1;rteszi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weisenbach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Caliebe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mundlos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>M&#x000e9;hes</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia.</article-title>
            <source>Eur J Pediatr</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>161</volume>
            <issue>11</issue>
            <fpage>619</fpage>
            <page-range>619-22</page-range>
            <pub-id pub-id-type="pmid">12424590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agustina</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Asyifa</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hernowo</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>The Role of Osteocalcin and Alkaline Phosphatase Immunohistochemistry in Osteosarcoma Diagnosis.</article-title>
            <source>Patholog Res Int</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>6346409</fpage>
            <pub-id pub-id-type="pmid">29854380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aparisi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Arborgh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ericsson</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Giant cell tumor of bone. Fine structural localization of alkaline phosphatase.</article-title>
            <source>Virchows Arch A Pathol Anat Histol</source>
            <year>1978</year>
            <month>Jul</month>
            <day>26</day>
            <volume>378</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-95</page-range>
            <pub-id pub-id-type="pmid">150116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r67">
          <label>67</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Breeland</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sinkler</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <chapter-title>Embryology, Bone Ossification</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">30969540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Izumi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Alkaline phosphatase as a biochemical maturity index in female adolescence.</article-title>
            <source>Spine (Phila Pa 1976)</source>
            <year>1993</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>15</issue>
            <fpage>2257</fpage>
            <page-range>2257-60</page-range>
            <pub-id pub-id-type="pmid">8278842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blumsohn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hannon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wrate</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>al-Dehaimi</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Colwell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eastell</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Biochemical markers of bone turnover in girls during puberty.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1994</year>
            <month>May</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>663</fpage>
            <page-range>663-70</page-range>
            <pub-id pub-id-type="pmid">7516828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonjour</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Chevalley</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rizzoli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The importance and relevance of peak bone mass in the prevalence of osteoporosis.</article-title>
            <source>Salud Publica Mex</source>
            <year>2009</year>
            <volume>51 Suppl 1</volume>
            <fpage>S5</fpage>
            <page-range>S5-17</page-range>
            <pub-id pub-id-type="pmid">19287894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Peak Bone Mass and Patterns of Change in Total Bone Mineral Density and Bone Mineral Contents From Childhood Into Young Adulthood.</article-title>
            <source>J Clin Densitom</source>
            <year>2016</year>
            <season>Apr-Jun</season>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>180</fpage>
            <page-range>180-91</page-range>
            <pub-id pub-id-type="pmid">25440183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Boning up on Wolff's Law: mechanical regulation of the cells that make and maintain bone.</article-title>
            <source>J Biomech</source>
            <year>2010</year>
            <month>Jan</month>
            <day>05</day>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>108</fpage>
            <page-range>108-18</page-range>
            <pub-id pub-id-type="pmid">19818443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teichtahl</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Wluka</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Wijethilake</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ghasem-Zadeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cicuttini</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Wolff's law in action: a mechanism for early knee osteoarthritis.</article-title>
            <source>Arthritis Res Ther</source>
            <year>2015</year>
            <month>Sep</month>
            <day>01</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>207</fpage>
            <pub-id pub-id-type="pmid">26324398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r74">
          <label>74</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bikle</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <chapter-title>Vitamin D: Production, Metabolism and Mechanisms of Action</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Feingold</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Anawalt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corpas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Dhatariya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaltsas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korbonits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kuohung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laferr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>McLachlan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>New</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <source>Endotext [Internet]</source>
            <publisher-name>MDText.com, Inc.</publisher-name>
            <publisher-loc>South Dartmouth (MA)</publisher-loc>
            <year>2021</year>
            <month>12</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">25905172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapuy</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Durr</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chapuy</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Age-related changes in parathyroid hormone and 25 hydroxycholecalciferol levels.</article-title>
            <source>J Gerontol</source>
            <year>1983</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-22</page-range>
            <pub-id pub-id-type="pmid">6600237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000f6;zen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>&#x000d6;z&#x00131;&#x0015f;&#x00131;k</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ba&#x0015f;aran</surname>
                <given-names>N&#x000c7;</given-names>
              </name>
            </person-group>
            <article-title>An overview and management of osteoporosis.</article-title>
            <source>Eur J Rheumatol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-56</page-range>
            <pub-id pub-id-type="pmid">28293453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r77">
          <label>77</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Porter</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Varacallo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Osteoporosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">28722930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r78">
          <label>78</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Rosen</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <chapter-title>The Epidemiology and Pathogenesis of Osteoporosis</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Feingold</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Anawalt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blackman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corpas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Herder</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Dhatariya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dungan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaltsas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korbonits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kuohung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laferr&#x000e8;re</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>McLachlan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>New</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <source>Endotext [Internet]</source>
            <publisher-name>MDText.com, Inc.</publisher-name>
            <publisher-loc>South Dartmouth (MA)</publisher-loc>
            <year>2020</year>
            <month>6</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">25905357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akkawi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zmerly</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Osteoporosis: Current Concepts.</article-title>
            <source>Joints</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-127</page-range>
            <pub-id pub-id-type="pmid">30051110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sheu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Diamond</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Bone mineral density: testing for osteoporosis.</article-title>
            <source>Aust Prescr</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>35</fpage>
            <page-range>35-9</page-range>
            <pub-id pub-id-type="pmid">27340320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirza</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Canalis</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>173</volume>
            <issue>3</issue>
            <fpage>R131</fpage>
            <page-range>R131-51</page-range>
            <pub-id pub-id-type="pmid">25971649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosen</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Endocrine disorders and osteoporosis.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-61</page-range>
            <pub-id pub-id-type="pmid">9229183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robinson</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Yaroslavskiy</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Griswold</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Zadorozny</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tourkova</surname>
                <given-names>IL</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6.</article-title>
            <source>Exp Cell Res</source>
            <year>2009</year>
            <month>Apr</month>
            <day>15</day>
            <volume>315</volume>
            <issue>7</issue>
            <fpage>1287</fpage>
            <page-range>1287-301</page-range>
            <pub-id pub-id-type="pmid">19331827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Osteocyte RANKL: new insights into the control of bone remodeling.</article-title>
            <source>J Bone Miner Res</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>499</fpage>
            <page-range>499-505</page-range>
            <pub-id pub-id-type="pmid">22354849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yasuda</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases.</article-title>
            <source>World J Orthop</source>
            <year>2013</year>
            <month>Oct</month>
            <day>18</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>207</fpage>
            <page-range>207-17</page-range>
            <pub-id pub-id-type="pmid">24147256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bord</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ireland</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Beavan</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Compston</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts.</article-title>
            <source>Bone</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>136</fpage>
            <page-range>136-41</page-range>
            <pub-id pub-id-type="pmid">12633785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kameda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yuasa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miyazawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shiokawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakamaru</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hiroi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hiura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kameda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Hakeda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kumegawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.</article-title>
            <source>J Exp Med</source>
            <year>1997</year>
            <month>Aug</month>
            <day>18</day>
            <volume>186</volume>
            <issue>4</issue>
            <fpage>489</fpage>
            <page-range>489-95</page-range>
            <pub-id pub-id-type="pmid">9254647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riggs</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>The mechanisms of estrogen regulation of bone resorption.</article-title>
            <source>J Clin Invest</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>106</volume>
            <issue>10</issue>
            <fpage>1203</fpage>
            <page-range>1203-4</page-range>
            <pub-id pub-id-type="pmid">11086020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Streicher</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heyny</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andrukhova</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Haigl</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Slavic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;ler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kollmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kantner</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sexl</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kleiter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hofbauer</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Kostenuik</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Erben</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells.</article-title>
            <source>Sci Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>25</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>6460</fpage>
            <pub-id pub-id-type="pmid">28744019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <article-title>Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.</article-title>
            <source>Menopause</source>
            <year>2010</year>
            <season>Jan-Feb</season>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-54; quiz 55-6</page-range>
            <pub-id pub-id-type="pmid">20061894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cranney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Papaioannou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zytaruk</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hanley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goltzman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hodsman</surname>
                <given-names>A</given-names>
              </name>
              <collab>Clinical Guidelines Committee of Osteoporosis Canada</collab>
            </person-group>
            <article-title>Parathyroid hormone for the treatment of osteoporosis: a systematic review.</article-title>
            <source>CMAJ</source>
            <year>2006</year>
            <month>Jul</month>
            <day>04</day>
            <volume>175</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-9</page-range>
            <pub-id pub-id-type="pmid">16818910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lv</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials.</article-title>
            <source>Osteoporos Int</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-70</page-range>
            <pub-id pub-id-type="pmid">30539271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Datta</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Osteoporotic fracture and parathyroid hormone.</article-title>
            <source>World J Orthop</source>
            <year>2011</year>
            <month>Aug</month>
            <day>18</day>
            <volume>2</volume>
            <issue>8</issue>
            <fpage>67</fpage>
            <page-range>67-74</page-range>
            <pub-id pub-id-type="pmid">22474638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Osteoblast-derived PTHrP is a physiological regulator of bone formation.</article-title>
            <source>J Clin Invest</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>115</volume>
            <issue>9</issue>
            <fpage>2322</fpage>
            <page-range>2322-4</page-range>
            <pub-id pub-id-type="pmid">16138187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Byun</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis.</article-title>
            <source>J Bone Metab</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-49</page-range>
            <pub-id pub-id-type="pmid">28326300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reid</surname>
                <given-names>IR</given-names>
              </name>
            </person-group>
            <article-title>Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies.</article-title>
            <source>Skeletal Radiol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>9</issue>
            <fpage>1191</fpage>
            <page-range>1191-6</page-range>
            <pub-id pub-id-type="pmid">21847749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maruotti</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Corrado</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cantatore</surname>
                <given-names>FP</given-names>
              </name>
            </person-group>
            <article-title>Osteoblast role in osteoarthritis pathogenesis.</article-title>
            <source>J Cell Physiol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>232</volume>
            <issue>11</issue>
            <fpage>2957</fpage>
            <page-range>2957-2963</page-range>
            <pub-id pub-id-type="pmid">28425564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r98">
          <label>98</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Vakiti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Anastasopoulou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mewawalla</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Malignancy-Related Hypercalcemia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">29494030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCauley</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine.</article-title>
            <source>J Bone Miner Res</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>1231</fpage>
            <page-range>1231-9</page-range>
            <pub-id pub-id-type="pmid">22549910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luparello</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Parathyroid Hormone-Related Protein (PTHrP): A Key Regulator of Life/Death Decisions by Tumor Cells with Potential Clinical Applications.</article-title>
            <source>Cancers (Basel)</source>
            <year>2011</year>
            <month>Jan</month>
            <day>20</day>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>396</fpage>
            <page-range>396-407</page-range>
            <pub-id pub-id-type="pmid">24212621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soki</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>McCauley</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>The multifaceted actions of PTHrP in skeletal metastasis.</article-title>
            <source>Future Oncol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>7</issue>
            <fpage>803</fpage>
            <page-range>803-17</page-range>
            <pub-id pub-id-type="pmid">22830401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suva</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Washam</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nicholas</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Bone metastasis: mechanisms and therapeutic opportunities.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>208</fpage>
            <page-range>208-18</page-range>
            <pub-id pub-id-type="pmid">21200394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shupp</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Kolb</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bussard</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.</article-title>
            <source>Cancers (Basel)</source>
            <year>2018</year>
            <month>Jun</month>
            <day>04</day>
            <volume>10</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">29867053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mannstadt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>J&#x000fc;ppner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gardella</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Receptors for PTH and PTHrP: their biological importance and functional properties.</article-title>
            <source>Am J Physiol</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>277</volume>
            <issue>5</issue>
            <fpage>F665</fpage>
            <page-range>F665-75</page-range>
            <pub-id pub-id-type="pmid">10564229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Karaplis</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Camirand</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>XF</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Kremer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.</article-title>
            <source>J Clin Invest</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>121</volume>
            <issue>12</issue>
            <fpage>4655</fpage>
            <page-range>4655-69</page-range>
            <pub-id pub-id-type="pmid">22056386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases.</article-title>
            <source>Int J Endocrinol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>7120979</fpage>
            <pub-id pub-id-type="pmid">30151009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carter</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Schipani</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics.</article-title>
            <source>Endocr Metab Immune Disord Drug Targets</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-76</page-range>
            <pub-id pub-id-type="pmid">16611165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Migliaccio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spera</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis.</article-title>
            <source>Clin Interv Aging</source>
            <year>2007</year>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-64</page-range>
            <pub-id pub-id-type="pmid">18044075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinstein</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Landes</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Bellido</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jilka</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Parfitt</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Manolagas</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.</article-title>
            <source>J Clin Invest</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>109</volume>
            <issue>8</issue>
            <fpage>1041</fpage>
            <page-range>1041-8</page-range>
            <pub-id pub-id-type="pmid">11956241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26378.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Basic and clinical pharmacology of glucocorticosteroids.</article-title>
            <source>Anesth Prog</source>
            <year>2013</year>
            <season>Spring</season>
            <volume>60</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-31; quiz 32</page-range>
            <pub-id pub-id-type="pmid">23506281</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
